|1.||Mizuguchi, Junichiro: 4 articles (11/2006 - 04/2002)|
|2.||Hata, Kikumi: 2 articles (11/2006 - 08/2004)|
|3.||Takada, Eiko: 2 articles (11/2006 - 04/2002)|
|4.||Takada, E: 2 articles (10/2003 - 02/2001)|
|5.||Mizuguchi, J: 2 articles (10/2003 - 02/2001)|
|6.||Toyota, H: 2 articles (10/2003 - 02/2001)|
|7.||Scott, D W: 2 articles (02/2001 - 01/2000)|
|8.||Carey, G B: 2 articles (02/2001 - 01/2000)|
|9.||Nisalak, Ananda: 1 article (01/2015)|
|10.||Goldenberg, David M: 1 article (01/2015)|
06/01/2009 - "Because c-myc is a downstream gene of both Notch signaling and BCR signaling, and GSI blocked c-myc expression in the presence of hDll1 and anti-IgM, Notch signaling might interact with BCR signaling at the level of c-myc expression to regulate proliferation and apoptosis of B-lymphoma cells."
11/15/2006 - "Requirement for JNK-dependent upregulation of BimL in anti-IgM-induced apoptosis in murine B lymphoma cell lines WEHI-231 and CH31."
06/01/2006 - "Taken together, these results indicate that IFN-alpha renders Daudi B lymphoma cells susceptible to anti-IgM-induced apoptosis, probably through upregulation of JNK activation."
05/15/2006 - "Treatment of Daudi B lymphoma cell line with a selective PKCbeta inhibitor, LY333531, inhibited anti-IgM-induced phosphorylation of BTK on Ser180 in a concentration-dependent manner, which was concomitant with an increase in BTK activation, and Ca2+ mobilization. "
10/01/2003 - "Thus, the anti-IgM-induced down-regulation of the nuclear Thy28 expression appears to correlate with the induction of apoptosis in Ramos B lymphoma cells."
08/01/2002 - "If active infection due to viral reactivation occurred during the abortion process, it cannot be accessed by antigenemia or anti-IgM assays. "
06/01/1985 - "Chronic Giardia muris infection in anti-IgM-treated mice. "
05/01/2001 - "The positive rate of anti-IgM antibody in ISSNHL was 7.2% suggesting that the silent mumps infection could be considered as one of the causative factors of ISSNHL even though its incidence is not so high. "
05/01/2001 - "From the measurement of anti-IgM antibody for mumps, it was possible to diagnose silent mumps infection in ISSNHL. "
05/01/2001 - "Measurement of anti-IgM antibody for mumps enables us to diagnose silent mumps infection. "
01/01/2000 - "Using anti-IgM Ab we nonspecifically depleted B cells in tumor-bearing mice, a treatment that resulted in significant reduction of tumor burden. "
01/01/2003 - "Only 5 (12.8%) of 39 patients with cancer were positive for anti IgM/VCA and all the controls showed negative results. "
04/01/1995 - "The results suggest that anti-IgM plays a decisive role in inducing tumor dormancy to BCL1 by acting as an agonist of IgM-mediated signal transduction pathways."
03/15/1982 - "The tumor incidence, mean tumor size, and tempo of regression were not modified by treatment with anti-IgM. "
03/15/1982 - "Tumor induction and immunity to tumors were studied following the injection of Moloney sarcoma virus (MSV) into mice whose B-lymphocyte functions had been suppressed by the chronic administration of anti-IgM antibodies. "
|4.||Burkitt Lymphoma (Burkitt's Lymphoma)
02/01/1999 - "In vitro studies identified three Burkitts lymphoma cell lines, Ramos, MUTU-I and Daudi, that were growth inhibited by anti-IgM antibody. "
10/10/1998 - "In this study we have also found that growth inhibition was induced by all the CCS agents chosen and by anti-IgM in various Burkitt's lymphoma lines. "
04/01/1995 - "Earlier studies showed that anti-IgM mAb treatment triggers apoptotic death in the Burkitt lymphoma-derived cell line, Ramos. "
07/01/2002 - "Role of Ca2+ in the intracellular signaling pathway of anti-IgM-induced apoptosis in the human B-cell line, MBC-1, established from Burkitt lymphoma."
12/01/1997 - "We previously established a B-cell line (MBC-1) from a patient with Burkitt's lymphoma at the leukaemic stage which demonstrated the typical morphology and internucleosomal DNA fragmentation of apoptotic cell death when treated with anti-IgM antibody. "
|5.||B-Cell Lymphoma (Lymphoma, B Cell)
11/01/2007 - "In this study, we characterized IL-4-activated signals that suppress anti-IgM-mediated apoptosis and growth arrest of CH31, a model B-cell lymphoma line. "
12/01/2001 - "In vitro assays showed that CD154-L929 cells can induce on B cells: IL-4-dependent proliferation, up-regulation of CD23, CD54 and class II molecules and can also rescue WEHI-231 B cell lymphoma from anti-IgM-induced apoptosis. "
11/15/1998 - "Evidence for an upper affinity threshold for anti-IgM-induced apoptosis in a human B-cell lymphoma."
01/01/1997 - "Hence, loss of c-myc in response to anti-IgM signals in these B-cell lymphomas leads to upregulation of p27, growth arrest and apoptosis. "
03/13/2001 - "In contrast, another human B cell lymphoma line, Daudi, less susceptible to B cell antigen receptor-mediated cell death, responded to anti-IgM with an early increase in intracellular pH (pH(i)). "
|2.||Immunoglobulin G (IgG)
|5.||Immunoglobulin M (IgM)
|6.||Proteins (Proteins, Gene)
|8.||Indicators and Reagents (Reagents)
|9.||Cyclin-Dependent Kinases (cdk Proteins)